Immunoglobulin Light-Chain Amyloidosis: From Basics to New Developments in Diagnosis, Prognosis and Therapy

Publisher： Karger

E-ISSN： 1421-9662|135|3|172-190

ISSN： 0001-5792

Source： Acta Haematologica, Vol.135, Iss.3, 2016-01, pp. : 172-190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Characteristics and Long-Term Outcome of Patients with Systemic Immunoglobulin Light-Chain Amyloidosis

By  

Acta Haematologica, Vol. 133, Iss. 4, 2014-12 ,pp. : 336-346

Karger

Access to resources Recommend Favorite

Induction therapy pre‐autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 91, Iss. 10, 2016-10 ,pp. : 984-988

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase II trial of lenalidomide, dexamethasone and cyclophosphamide for newly diagnosed patients with systemic immunoglobulin light chain amyloidosis

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 6, 2015-09 ,pp. : 804-813

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of hepatic amyloid light‐chain amyloidosis with bortezomib and dexamethasone in a liver transplant patient

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 10, 2015-10 ,pp. : E150-E155

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Patient with Multiple Myeloma, Amyloidosis and Light-Chain Deposition Disease in Kidneys with a Long Survival

By  

Acta Haematologica, Vol. 101, Iss. 4, 1999-07 ,pp. : 202-205

Karger

Access to resources Recommend Favorite